ELIAS JOSEPH JABBOUR to Chemotherapy, Adjuvant
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Chemotherapy, Adjuvant.
Connection Strength
0.054
-
Long-term outcomes in the second-line treatment of chronic myeloid leukemia: a review of tyrosine kinase inhibitors. Cancer. 2011 Mar 01; 117(5):897-906.
Score: 0.054